Ocular Therapeutix Inc (OCUL)
6.17
+0.30
(+5.11%)
USD |
NASDAQ |
May 03, 16:00
6.16
-0.01
(-0.16%)
After-Hours: 20:00
Ocular Therapeutix Accounts Receivable (Quarterly): 26.18M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.18M |
September 30, 2023 | 23.59M |
June 30, 2023 | 27.31M |
March 31, 2023 | 21.12M |
December 31, 2022 | 21.32M |
September 30, 2022 | 19.80M |
June 30, 2022 | 20.48M |
March 31, 2022 | 23.21M |
December 31, 2021 | 21.14M |
September 30, 2021 | 19.55M |
June 30, 2021 | 18.73M |
March 31, 2021 | 13.63M |
December 31, 2020 | 12.25M |
September 30, 2020 | 7.779M |
June 30, 2020 | 2.874M |
March 31, 2020 | 3.429M |
December 31, 2019 | 2.548M |
September 30, 2019 | 1.114M |
June 30, 2019 | 0.615M |
March 31, 2019 | 0.276M |
December 31, 2018 | 0.201M |
Date | Value |
---|---|
September 30, 2018 | 0.24M |
June 30, 2018 | 0.285M |
March 31, 2018 | 0.17M |
December 31, 2017 | 0.226M |
September 30, 2017 | 0.278M |
June 30, 2017 | 0.211M |
March 31, 2017 | 0.244M |
December 31, 2016 | 0.25M |
September 30, 2016 | 0.243M |
June 30, 2016 | 0.223M |
March 31, 2016 | 0.227M |
December 31, 2015 | 0.193M |
September 30, 2015 | 0.189M |
June 30, 2015 | 0.164M |
March 31, 2015 | 0.352M |
December 31, 2014 | 0.329M |
September 30, 2014 | 0.054M |
June 30, 2014 | 0.061M |
March 31, 2014 | 0.306M |
December 31, 2013 | 0.269M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.615M
Minimum
Jun 2019
27.31M
Maximum
Jun 2023
15.09M
Average
19.55M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
Amgen Inc | 6.776B |
Assertio Holdings Inc | 47.66M |
CytomX Therapeutics Inc | 3.432M |
EyePoint Pharmaceuticals Inc | 0.805M |
Regeneron Pharmaceuticals Inc | 5.222B |